Inhibikase Therapeutics: Expand the process development work of IKT-001PRO to support late-stage clinical development and NDA batch requirements.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.